Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 05/25/18

Elise C. Kohn, MD

Elise C. Kohn, MD

Head, Gynecologic Cancer Therapeutics

To promote scientifically driven and practice-changing trials, Dr. Kohn reviews, coordinates, and oversees development and execution of phase 2-3 trials in gynecologic cancers and gastrointestinal neuroendocrine cancers. She also provides disease expertise for early phase trials in these cancers. Dr. Kohn also applies her expertise to the oversight and guidance of the NCTN Core Correlative Science Committee (CCSC). The CCSC reviews proposals for correlative science to be applied to remaining biospecimens from NCTN clinical trials after protocol-specified integrated endpoints are completed.

Dr. Kohn trained at the University of Michigan and received Medical Oncology training at the National Cancer Institute (NCI). Dr. Kohn spent over 2 decades overseeing a laboratory and clinical program in the NCI intramural program focused on signal transduction molecular targets in invasion, metastasis, and angiogenesis, and proteomic applications, applied towards ovarian cancer. Her clinical program focused on application of novel agents and translational opportunities to women's cancers, especially ovarian cancer, via phase 1 and 2 studies. She is now Head, Gynecologic Cancer Therapeutics in the NCI Cancer Therapy Evaluation Program, where she coordinates development and execution of the advanced phase 2 and the phase 3 gynecologic cancer clinical trials portfolio. Dr. Kohn also oversees and guides studies in gastroesophagopancreatic neuroendocrine cancers.

Dr. Kohn serves on education committees for the Society of Gynecologic Oncology and ASCO, and has completed a tour on the integration panel of the Department of Defense Ovarian Cancer Research Program, on which she also served 2 years as panel chair. She is a recently retired career officer in the US Public Health Service. Dr. Kohn has received the Ovarian Cancer National Alliance's Rosalind Franklin Excellence in Ovarian Cancer Research Award, NIH Director's Merit Awards, and Diversity, and Mentoring Awards. Dr. Kohn was elected a Fellow of the American Association for the Advancement of Science in 2002.

Contact Information:
National Cancer Institute
9609 Medical Center Dr., MSC 9739
For USPS: Bethesda, MD 20892-9739
For Express and Courier: Rockville, MD 20850
Phone: 240-276-6560
Fax: 240-276-7892

About the Branch Chief

Meg Mooney, MD, MS Meg Mooney, MD, MS, is the Associate Director of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis (DCTD), at the National Cancer Institute (NCI), and she is also the Chief of the Clinical Investigations Branch (CIB) in CTEP. More…